Editorial Policy

Our Commitment to Quality

At ozempic.ng, we are committed to providing accurate, evidence-based information about GLP-1 weight loss medications. Our editorial standards ensure that all content meets the highest quality benchmarks for health information.

Content Creation Process

1. Research: All content is based on peer-reviewed medical literature, clinical trials, and guidelines from recognized health authorities.
2. Writing: Content is written by health writers with experience in medical and pharmaceutical topics.
3. Medical Review: All health-related content is reviewed by qualified healthcare professionals before publication.
4. Editorial Review: Content undergoes editorial review for accuracy, clarity, and compliance with our guidelines.
5. Publication: Only content that meets all quality standards is published.

Sources We Trust

We cite information from reputable sources including:

• Peer-reviewed medical journals (NEJM, JAMA, The Lancet)
• Government health agencies (FDA, NAFDAC, WHO)
• Academic medical institutions
• Established medical databases (PubMed, Cochrane Library)
• Pharmaceutical manufacturer prescribing information

Content Updates

Medical knowledge evolves. We regularly review and update our content to reflect:

• New clinical trial results
• Updated treatment guidelines
• Regulatory changes
• Reader feedback and questions

Each article displays its last review date. Articles are reviewed at minimum every 12 months.

Editorial Independence

Our editorial team operates independently. While ozempic.ng offers weight loss medication services, our educational content is created to inform, not to promote sales. We present balanced information including potential risks, side effects, and contraindications.

Corrections Policy

If we discover an error, we correct it promptly and transparently. Significant corrections are noted at the bottom of the article. If you believe you've found an error, please contact us.

Medical Disclaimer